In ovarian CCC, ABCF2 expression was associated with chemoresistance and OS (Tsuda et al, 2005a, 2005b; Ogawa et al, 2006), while in breast cancer, lack of ABCF2 expression was associated with increased disease-free survival (Ogawa et al, 2006). The gene discussed is ABCF2; the disease is breast cancer.